A new era of risk prediction for patients with high-risk melanoma
A new era of risk prediction for patients with high-risk melanoma
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
In The Lancet Oncology, Robert C Stassen and colleagues1 report the development of a new model to predict recurrence-free survival and melanoma-specific survival in people with stage II or III melanoma. Since the introduction in 2018 of adjuvant systemic therapies for use after surgical resection of high-risk melanoma, there has been growing awaren...
Alternative Titles
Full title
A new era of risk prediction for patients with high-risk melanoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3022571888
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3022571888
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(24)00101-3
